Document Detail


The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome.
MedLine Citation:
PMID:  2847889     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We have investigated the combined use of metyrapone and sodium valproate in the treatment of five cases of dexamethasone-suppressible Cushing's disease and one case with dexamethasone non-suppressible disease. Metyrapone alone reduced 24 h urinary free cortisol (UFC) and plasma cortisol concentrations. Addition of sodium valproate to metyrapone produced a further reduction in these values in five of six patients with a reduction in plasma ACTH in three of five patients who had dexamethasone-suppressible disease. Plasma 11-deoxycortisol increased markedly on metyrapone. However, addition of valproate produced a further rise in 11-deoxycortisol values in four of five patients including the patient with dexamethasone non-suppressible disease. The results suggest that valproate may be a useful addition to metyrapone in the medical treatment of some patients with Cushing's syndrome and that it may have an action both at the hypothalamus and peripherally.
Authors:
S S Nussey; P Price; J S Jenkins; A R Altaher; B Gillham; M T Jones
Related Documents :
17236439 - Puberty: timing is everything.
2619099 - Testosterone therapy in klinefelter's syndrome (a prolonged observation).
20190129 - Alteration of delay and trace eyeblink conditioning in fibromyalgia patients.
825329 - Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
20627449 - Cortisol levels and adrenal response in severe community-acquired pneumonia: a systemat...
24110849 - Comparison of complexity of emg signals between a normal subject and a patient after st...
9096449 - Is the red cell morphology really useful to detect the source of hematuria?
7352039 - Blood pressure in terminal renal failure. fluid spaces and the renin-angiotensin-system.
3943439 - Pharmacokinetics and bioavailability of ranitidine in normal subjects and cirrhotic pat...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical endocrinology     Volume:  28     ISSN:  0300-0664     ISO Abbreviation:  Clin. Endocrinol. (Oxf)     Publication Date:  1988 Apr 
Date Detail:
Created Date:  1988-12-28     Completed Date:  1988-12-28     Revised Date:  2009-09-29    
Medline Journal Info:
Nlm Unique ID:  0346653     Medline TA:  Clin Endocrinol (Oxf)     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  373-80     Citation Subset:  IM    
Affiliation:
Department of Medicine, St George's Hospital Medical School, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenocorticotropic Hormone / blood
Adult
Aged
Cortodoxone / blood
Cushing Syndrome / drug therapy*,  metabolism
Drug Therapy, Combination
Female
Humans
Hydrocortisone / metabolism
Male
Middle Aged
Pyridines / therapeutic use*
Valproic Acid / therapeutic use*
Grant Support
ID/Acronym/Agency:
//Wellcome Trust
Chemical
Reg. No./Substance:
0/Pyridines; 152-58-9/Cortodoxone; 17286-92-9/metapyrone; 50-23-7/Hydrocortisone; 9002-60-2/Adrenocorticotropic Hormone; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alpha-adrenergic receptor stimulation during simulated ischemia and reperfusion in canine cardiac Pu...
Next Document:  IgG subclass distribution of antiviral antibodies in common variable immunodeficiency: effect of sub...